128 related articles for article (PubMed ID: 3084765)
21. Mercurial-induced alterations in neuronal divalent cation homeostasis.
Denny MF; Atchison WD
Neurotoxicology; 1996; 17(1):47-61. PubMed ID: 8784818
[TBL] [Abstract][Full Text] [Related]
22. Heavy metals: effects on synaptic transmission.
Cooper GP; Suszkiw JB; Manalis RS
Neurotoxicology; 1984; 5(3):247-66. PubMed ID: 6097846
[TBL] [Abstract][Full Text] [Related]
23. Methylmercury mobilizes Ca++ from intracellular stores sensitive to inositol 1,4,5-trisphosphate in NG108-15 cells.
Hare MF; Atchison WD
J Pharmacol Exp Ther; 1995 Mar; 272(3):1016-23. PubMed ID: 7891311
[TBL] [Abstract][Full Text] [Related]
24. Alterations of spontaneous and evoked release of acetylcholine during dithiobiuret-induced neuromuscular weakness.
Atchison WD
J Pharmacol Exp Ther; 1989 Jun; 249(3):735-43. PubMed ID: 2499675
[TBL] [Abstract][Full Text] [Related]
25. Comparative effects of methylmercury on parallel-fiber and climbing-fiber responses of rat cerebellar slices.
Yuan Y; Atchison WD
J Pharmacol Exp Ther; 1999 Mar; 288(3):1015-25. PubMed ID: 10027838
[TBL] [Abstract][Full Text] [Related]
26. Evidence for interactions between intracellular calcium stores during methylmercury-induced intracellular calcium dysregulation in rat cerebellar granule neurons.
Limke TL; Otero-Montañez JK; Atchison WD
J Pharmacol Exp Ther; 2003 Mar; 304(3):949-58. PubMed ID: 12604669
[TBL] [Abstract][Full Text] [Related]
27. Changes in miniature end-plate currents due to high potassium and calcium at the frog neuromuscular junction.
Glavinović MI
Synapse; 1988; 2(6):636-43. PubMed ID: 3264941
[TBL] [Abstract][Full Text] [Related]
28. Effects of aminoglycoside antibiotics on the neuromuscular junction: Part I.
Yamada S; Kuno Y; Iwanaga H
Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):130-8. PubMed ID: 3699939
[TBL] [Abstract][Full Text] [Related]
29. Comparative action of methylmercury and divalent inorganic mercury on nerve terminal and intraterminal mitochondrial membrane potentials.
Hare MF; Atchison WD
J Pharmacol Exp Ther; 1992 Apr; 261(1):166-72. PubMed ID: 1560362
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological characterization of the calcium-insensitive, intermittent acetylcholine release at the rat neuromuscular junction.
Tabti N; Lupa MT; Yu SP; Thesleff S
Acta Physiol Scand; 1986 Nov; 128(3):429-36. PubMed ID: 3788620
[TBL] [Abstract][Full Text] [Related]
31. Effect of sodium and calcium channel blockade on the increase in spontaneous transmitter release produced by the mitochondrial inhibitor, dinitrophenol.
Moffatt EJ; Miyamoto MD
J Pharmacol Exp Ther; 1988 Feb; 244(2):613-8. PubMed ID: 2450196
[TBL] [Abstract][Full Text] [Related]
32. Extra- and intracellular sphingosylphosphorylcholine promote spontaneous transmitter release from frog motor nerve endings.
Brailoiu E; Dun NJ
Mol Pharmacol; 2003 Jun; 63(6):1430-6. PubMed ID: 12761354
[TBL] [Abstract][Full Text] [Related]
33. Calcium inflow-dependent protein kinase C activity is involved in the modulation of transmitter release in the neuromuscular junction of the adult rat.
Santafé MM; Lanuza MA; Garcia N; Tomàs J
Synapse; 2005 Aug; 57(2):76-84. PubMed ID: 15906390
[TBL] [Abstract][Full Text] [Related]
34. Intraterminal Ca(2+) and spontaneous transmitter release at the frog neuromuscular junction.
Angleson JK; Betz WJ
J Neurophysiol; 2001 Jan; 85(1):287-94. PubMed ID: 11152728
[TBL] [Abstract][Full Text] [Related]
35. Pharmacology of the alkaloid pumiliotoxin-B. II. Possible involvement of calcium and sodium-dependent processes in nerve and skeletal muscle.
Rao KS; Warnick JE; Daly JW; Albuquerque EX
J Pharmacol Exp Ther; 1987 Nov; 243(2):775-83. PubMed ID: 3500302
[TBL] [Abstract][Full Text] [Related]
36. Is hyperosmotic neurosecretion from motor nerve endings a calcium-dependent process?
Shimoni Y; Alnaes E; Rahamimoff R
Nature; 1977 May; 267(5607):170-2. PubMed ID: 16073435
[TBL] [Abstract][Full Text] [Related]
37. Effects of Ca2+ channel blocker neurotoxins on transmitter release and presynaptic currents at the mouse neuromuscular junction.
Katz E; Protti DA; Ferro PA; Rosato Siri MD; Uchitel OD
Br J Pharmacol; 1997 Aug; 121(8):1531-40. PubMed ID: 9283685
[TBL] [Abstract][Full Text] [Related]
38. Effects of 4-aminopyridine and 3,4-diaminopyridine on transmitter release at the neuromuscular junction.
Thomsen RH; Wilson DF
J Pharmacol Exp Ther; 1983 Oct; 227(1):260-5. PubMed ID: 6137556
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of mitochondrial Ca2+ release diminishes the effectiveness of methyl mercury to release acetylcholine from synaptosomes.
Levesque PC; Hare MF; Atchison WD
Toxicol Appl Pharmacol; 1992 Jul; 115(1):11-20. PubMed ID: 1378659
[TBL] [Abstract][Full Text] [Related]
40. Reduced safety factor for neuromuscular transmission and abnormal quantal secretion precede neuromuscular weakness induced by dithiobiuret.
Atchison WD
Toxicol Appl Pharmacol; 1990 Nov; 106(2):234-44. PubMed ID: 2175053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
